Evidence map›Paper›PMID 34911820›Full record

ArticleCold Spring Harbor protocols2022

Tissue-Targeted CRISPR-Cas9-Mediated Genome Editing of Multiple Homeologs in F

Mark E Corkins, Bridget D DeLay, Rachel K Miller

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cold Spring Harbor protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. CRISPR/Cas systems: Delivery and application in gene therapy.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mark E CorkinsDepartment of Pediatrics, Pediatric Research Center, University of Texas Health Science Center McGovern Medical School, Houston, Texas 77030, USA; Mark.E.Corkins@uth.tmc.edu Rachel.K.Miller@uth.tmc.edu.ORCID 0000-0001-8261-6025
Bridget D DeLayDepartment of Pediatrics, Pediatric Research Center, University of Texas Health Science Center McGovern Medical School, Houston, Texas 77030, USA.
Rachel K MillerDepartment of Pediatrics, Pediatric Research Center, University of Texas Health Science Center McGovern Medical School, Houston, Texas 77030, USA; Mark.E.Corkins@uth.tmc.edu Rachel.K.Miller@uth.tmc.edu.ORCID 0000-0001-6381-7198
The University of Texas Health Science Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Novel Role of Nephron Epithelialization in Nuclear SignalingR01DK115655 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Rachel Katherine Miller · 2019 to 2026
$2.3M
The Role of Planar Cell Polarity Signals in Shaping Kidney TubulesK01DK092320 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MILLER, RACHEL KATHERINE · 2012 to 2016
$584k
Role of p53 in Kidney Development: Modeling Renal Anomalies of Li-Fraumeni PatientsR03DK118771 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, RACHEL KATHERINE · 2018 to 2019
$231k
NIDDK NIH HHS K01 DK092320NIDDK NIH HHS R01 DK115655NIDDK NIH HHS R03 DK118771
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR-Cas SystemsGene EditingAnimalsCRISPR-Associated Protein 9RNA, Guide, CRISPR-Cas SystemsXenopus laevisCRISPR-Associated Protein 9RNA, Guide, CRISPR-Cas Systems

Identifiers

PMID34911820
PMCPMC10829535
OpenAlexW4200275575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.